Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ FAM96B Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA559598
Description
Immunogen sequence: LIYQRSGERP VTAGEEDEQV PDSIDAREIF DLIRSINDPE HPLTLEELNV VEQVRVQVSD PESTVAVAFT PTIP Highest antigen sequence identity to the following orthologs: Mouse - 96%, Rat - 96%.
Signs of Rubinstein-Taybi include mental retardation and predisposition to tumor growth and white blood cell neoplasias. Crohn's disease is a gastrointestinal inflammatory condition associated with chromosome 16 through the NOD2 gene. An association with systemic lupus erythematosis and a number of other autoimmune disorders with the pericentromeric region of chromosome 16 has led to the identification of SLC5A11 as a potential autoimmune modifier. The FAM96B gene product has been provisionally designated FAM96B pending further characterization.
Specifications
FAM96B | |
Polyclonal | |
Unconjugated | |
CIAO2B | |
1110019N10Rik; CGI-128; CIAB; Ciao2b; Cytosolic iron-sulfur assembly component 2B; Fam96b; family with sequence similarity 96 member B; family with sequence similarity 96, member B; HSPC118; MIP18; Mitotic spindle-associated MMXD complex subunit MIP18; MSS19-interacting protein of 18 kDa; Protein FAM96B; RGD1311762 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
51647 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.3 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q9Y3D0 | |
CIAO2B | |
Recombinant protein corresponding to Human FAM96B. Recombinant protein control fragment (Product #RP-98714). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction